Preclinical Evaluation of Engineered Oncolytic Herpes Simplex Virus for the Treatment of Pediatric Solid Tumors

Overview of attention for article published in PLOS ONE, January 2014

Altmetric Badge

Mentioned by

twitter: 3 X users

patent: 2 patents

Citations

dimensions_citation: 10 Dimensions

Readers on

mendeley: 21 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 5 X posts from 3 X users, with an upper bound of 4,783 followers.

Preclinical evaluation of engineered oncolytic herpes simplex virus for the treatment of pediatric solid tumors. http://t.co/9i2csacUYT

Reply Repost Favourite

@portefeuillefun @JSwatercooler @JohnCFierce preclinical #M002 data: hepatoblastoma, kidney tumor, and renal sarcoma http://t.co/f2Uekfc2Dl

Reply Repost Favourite

$MDGEF €MDG1 #Medigene #oHSV: preclinical support for M032 in Pediatric Solid Tumors http://t.co/EQd8QnEJYh

Reply Repost Favourite

Preclinical Evaluation of Engineered Oncolytic Herpes Simplex Virus for the Treatment of Pediatric Solid Tumors #oHSV http://t.co/oEeJKomcVJ

Reply Repost Favourite

Preclinical Evaluation of Engineered Oncolytic Herpes Simplex Virus for the Treatment of Pediatric Solid Tumors #oHSV http://t.co/oEeJKomcVJ

Reply Repost Favourite